Rohan H C Palmer1, John E McGeary2,3,4, Valerie S Knopik5, L Cinnamon Bidwell6, Jane M Metrik2,4. 1. a Department of Psychology at Emory University, Behavioral Genetics of Addiction Laboratory , Atlanta , GA , USA. 2. b Providence Veterans Affairs Medical Center , Providence , RI , USA. 3. c Department of Psychiatry and Human Behavior, Alpert Medical School, Brown University , Providence , RI , USA. 4. d Center for Alcohol and Addiction Studies, Brown University School of Public Health , Providence , RI , USA. 5. e Human Development and Family Studies, Purdue University , West Lafayette , IN , USA. 6. f Institute for Cognitive Science, University of Colorado at Boulder , Boulder , CO , USA.
Abstract
Background: Polymorphisms in cannabinoid receptor type 1 (encoded by CNR1) and fatty acid amide hydrolase (encoded by FAAH) have been associated with cannabis dependence, but it remains unknown whether variation within these genes influences cannabis' acute effects on affect. Objective: Conduct a secondary data analysis study to determine whether previously observed acute effects of tetrahydrocannabinol (THC) on mood was dependent upon variation in CNR1 and FAAH. Methods: A balanced placebo design was used crossing marijuana administration (i.e., 0% THC vs. 2.8% THC) with stimulus expectancy. Participants (N = 118; 64% male) provided DNA and completed the Profile of Mood States questionnaire prior to and after smoking. Haplotypes were constructed from genotyped single nucleotide polymorphisms for CNR1 (rs1049353 and rs806368) and FAAH (rs4141964, rs324420, and rs11576941); rs2023239 (CNR1) and rs6703669 (FAAH) were not part of a phased haplotype block. Analyses tested both main and interaction effects for genotype across CNR1 and FAAH, and drug, and expectancy effects. Results:THC increased levels of POMS Tension-Anxiety and Confusion-Bewilderment over and above the effects of variation in CNR1 and FAAH. Significant drug X genotype/haplotype and expectancy X genotype/haplotype interaction effects were observed for some but not all mood states [e.g., 'C' allele carriers of rs2023239 who received THC had higher levels of Anger-Hostility (β= 0.29 (0.12), p= .02) compared to those who received placebo]. Conclusion: These preliminary findings suggest individual differences in mood states after using marijuana depend on genetic variation. Such information might be useful in understanding either motivation for use of marijuana and/or risk for associated behaviors.
RCT Entities:
Background: Polymorphisms in cannabinoid receptor type 1 (encoded by CNR1) and fatty acid amide hydrolase (encoded by FAAH) have been associated with cannabis dependence, but it remains unknown whether variation within these genes influences cannabis' acute effects on affect. Objective: Conduct a secondary data analysis study to determine whether previously observed acute effects of tetrahydrocannabinol (THC) on mood was dependent upon variation in CNR1 and FAAH. Methods: A balanced placebo design was used crossing marijuana administration (i.e., 0% THC vs. 2.8% THC) with stimulus expectancy. Participants (N = 118; 64% male) provided DNA and completed the Profile of Mood States questionnaire prior to and after smoking. Haplotypes were constructed from genotyped single nucleotide polymorphisms for CNR1 (rs1049353 and rs806368) and FAAH (rs4141964, rs324420, and rs11576941); rs2023239 (CNR1) and rs6703669 (FAAH) were not part of a phased haplotype block. Analyses tested both main and interaction effects for genotype across CNR1 and FAAH, and drug, and expectancy effects. Results:THC increased levels of POMS Tension-Anxiety and Confusion-Bewilderment over and above the effects of variation in CNR1 and FAAH. Significant drug X genotype/haplotype and expectancy X genotype/haplotype interaction effects were observed for some but not all mood states [e.g., 'C' allele carriers of rs2023239 who received THC had higher levels of Anger-Hostility (β= 0.29 (0.12), p= .02) compared to those who received placebo]. Conclusion: These preliminary findings suggest individual differences in mood states after using marijuana depend on genetic variation. Such information might be useful in understanding either motivation for use of marijuana and/or risk for associated behaviors.
Authors: O Gunduz-Cinar; K P MacPherson; R Cinar; J Gamble-George; K Sugden; B Williams; G Godlewski; T S Ramikie; A X Gorka; S O Alapafuja; S P Nikas; A Makriyannis; R Poulton; S Patel; A R Hariri; A Caspi; T E Moffitt; G Kunos; A Holmes Journal: Mol Psychiatry Date: 2012-06-12 Impact factor: 15.992
Authors: Matthew E Sloan; Joshua L Gowin; Jia Yan; Melanie L Schwandt; Primavera A Spagnolo; Hui Sun; Colin A Hodgkinson; David Goldman; Vijay A Ramchandani Journal: Addict Biol Date: 2017-02-01 Impact factor: 4.280
Authors: Christie A Hartman; Christian J Hopfer; Brett Haberstick; Soo Hyun Rhee; Thomas J Crowley; Robin P Corley; John K Hewitt; Marissa A Ehringer Journal: Drug Alcohol Depend Date: 2009-05-14 Impact factor: 4.492
Authors: Arpana Agrawal; Michele L Pergadia; Scott F Saccone; Michael T Lynskey; Jen C Wang; Nicholas G Martin; Dixie Statham; Anjali Henders; Megan Campbell; Robertino Garcia; Ulla Broms; Richard D Todd; Alison M Goate; John Rice; Jaakko Kaprio; Andrew C Heath; Grant W Montgomery; Pamela A F Madden Journal: Arch Gen Psychiatry Date: 2008-06
Authors: Dominika Szkatuła; Edward Krzyżak; Szczepan Mogilski; Jacek Sapa; Barbara Filipek; Piotr Świątek Journal: Molecules Date: 2020-12-12 Impact factor: 4.411
Authors: José J Martínez-Magaña; Alma D Genis-Mendoza; Vanessa González-Covarrubias; Isela E Juárez-Rojop; Carlos A Tovilla-Zárate; Xavier Soberón; Nuria Lanzagorta; Humberto Nicolini Journal: Braz J Psychiatry Date: 2022 Mar-Abr
Authors: Lisa Bornscheuer; Andreas Lundin; Yvonne Forsell; Catharina Lavebratt; Philippe A Melas Journal: Sci Rep Date: 2022-03-23 Impact factor: 4.379